ZION
53
4
UNH
55
7
IFF
48
4
ACN
40
2
MLM
69
2
BAX
51
4
VRTX
60
2
VLO
35
3
CFG
44
4
HCA
39
4
AMG
44
6
PDCO
60
13
IVZ
40
2
GOOGL
66
2
CME
65
3
DOV
71
2
HAS
59
4
WAT
48
4
CHK
27
7
NEM
57
-7
ZION
53
4
UNH
55
7
IFF
48
4
ACN
40
2
MLM
69
2
BAX
51
4
VRTX
60
2
VLO
35
3
CFG
44
4
HCA
39
4
AMG
44
6
PDCO
60
13
IVZ
40
2
GOOGL
66
2
CME
65
3
DOV
71
2
HAS
59
4
WAT
48
4
CHK
27
7
NEM
57
-7
Financhill
Back

NovoCure Stock Predictions

My #1 Coin is...

All the details are on the next page.
Sell
35

NVCR
NovoCure

Last Price:
12.07
Seasonality Move:
12.01%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 33.2% based on the past 8 years of stock performance.
  • NovoCure has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $11.83. The Score for NVCR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 33.2% based on the past 8 years of stock performance.

NovoCure Stock Rating

Sell
35
NovoCure (NVCR) is a Sell

Is NovoCure overpriced?

  • NovoCure has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
83.60
52-Week Low:
10.87

Prediction Charts

Market Cap:
1.27B
Price in USD:
11.83
Volume:
784.38K
Beta:
0.94

Technical Analysis

SMA50:
14.68
SMA100:
14.18
SMA200:
18.24
52-Wk Change:
-81.16%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 11.83 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-3 14.08 14.42 14.79 14.00
Apr-4 14.60 14.29 14.79 14.22
Apr-5 14.06 13.74 14.24 13.62
Apr-8 13.80 14.18 14.21 13.62
Apr-9 14.20 14.90 15.46 14.18
Apr-10 14.48 14.60 14.74 14.11
Apr-11 14.90 14.14 15.00 14.03
Apr-12 14.01 13.57 14.12 13.40
Apr-15 13.60 12.72 13.72 12.63
Apr-16 12.56 12.46 12.71 12.20
Apr-17 12.40 12.05 12.45 12.04
Apr-18 12.05 12.05 12.45 11.89
Apr-19 11.89 12.09 12.32 11.89
Apr-22 12.19 11.83 12.19 11.70

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.